Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial.
- DOI
- 10.1016/j.lanepe.2025.101346
- Published
- 2025 Aug
- Container
- The Lancet regional health. Europe
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lanepe.2025.101346,
title = {Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial.},
author = {Gamborg M and Grand MK and Grell K and Rosthøj S and Pedersen-Bjergaard U and Torp-Pedersen C and Mørch LS},
year = {2025},
journal = {The Lancet regional health. Europe},
doi = {10.1016/j.lanepe.2025.101346},
url = {https://doi.org/10.1016/j.lanepe.2025.101346}
}RIS
TY - JOUR TI - Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial. AU - Gamborg M AU - Grand MK AU - Grell K AU - Rosthøj S AU - Pedersen-Bjergaard U AU - Torp-Pedersen C AU - Mørch LS PY - 2025 JO - The Lancet regional health. Europe DO - 10.1016/j.lanepe.2025.101346 UR - https://doi.org/10.1016/j.lanepe.2025.101346 ER -
APA
M, G., MK, G., K, G., S, R., U, P., C, T., & LS, M. (2025). Long-term cancer risk in users of GLP-1 agonists in Denmark: a nationwide emulated trial.. The Lancet regional health. Europe. https://doi.org/10.1016/j.lanepe.2025.101346
Source records
- pubmed · retrieved 2026-09-26T20:24:04.098Z